PTK2 and PTPN11 expression in myelodysplastic syndromes
DOI:
https://doi.org/10.1590/clin.v68i10.77016Abstract
OBJECTIVE: The aim of this study was to evaluate the expression of protein tyrosine kinase 2 and protein tyrosine phosphatase non-receptor type 11, which respectively encode focal adhesion kinase protein and src homology 2 domain-containing protein-tyrosine phosphatase 2, in hematopoietic cells from patients with myelodysplastic syndromes. METHODS: Protein tyrosine kinase 2 and tyrosine phosphatase non-receptor type 11 expressions were analyzed by quantitative polymerase chain reaction in bone marrow cells from patients with myelodysplastic syndromes and healthy donors. RESULTS: Protein tyrosine kinase 2 and tyrosine phosphatase non-receptor type 11 expressions did not significantly differ between normal cells and myelodysplastic cells. CONCLUSIONS: Our data suggest that despite the relevance of focal adhesion kinase and src homology 2 domain-containing protein-tyrosine phosphatase 2 in hematopoietic disorders, their mRNA expression do not significantly differ between total bone marrow cells from patients with myelodysplastic syndromes and healthy donors.Downloads
Download data is not yet available.
Downloads
Published
2013-10-01
Issue
Section
Rapid Communications
How to Cite
PTK2 and PTPN11 expression in myelodysplastic syndromes. (2013). Clinics, 68(10), 1371-1375. https://doi.org/10.1590/clin.v68i10.77016